For those following Novavax (NVAX) at home, we previously wrote two free part I and part II newsletters on it. In this post, we cover a very detailed look (part III) for our paid subscriber group that covers in detail today’s NVAX phase 3 results from their US/Mexico trial and deep-dives on the data and company financials.
Today, NVAX reported Phase 3 r…